In contrast, in another study to demonstrate the function of Brca2 in the progression of pancreatic cancer, the mouse models that combined pancreas specific KrasG12D activation and TP53 deletion with BRCA2 inactivation were generated. This evidence concerns the gene TP53 and familial pancreatic carcinoma.